Tang Capital Management

Tang Capital Management as of June 30, 2012

Portfolio Holdings for Tang Capital Management

Tang Capital Management holds 30 positions in its portfolio as reported in the June 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spectrum Pharmaceuticals 18.2 $87M 5.6M 15.56
Nektar Therapeutics note 3.250% 9/2 16.5 $79M 79M 1.00
Amylin Pharmaceuticals 11.7 $56M 2.0M 28.20
Pdl Biopharma Inc note 2.875% 2/1 9.0 $43M 38M 1.15
Human Genome Sciences 7.9 $38M 2.9M 13.13
Mannkind Corp note 3.750%12/1 4.5 $22M 42M 0.52
Dendreon Corp note 3.8 $18M 27M 0.69
Salix Pharmaceuticals 3.4 $16M 300k 54.44
DepoMed 3.2 $16M 2.7M 5.69
Intermune Inc note 2.500% 9/1 2.7 $13M 17M 0.77
OncoGenex Pharmaceuticals 2.3 $11M 833k 13.44
Vanda Pharmaceuticals (VNDA) 2.2 $11M 2.4M 4.40
Savient Pharmaceuticals note 2.2 $11M 39M 0.27
Isis Pharmaceuticals Inc Del note 2.625% 2/1 1.6 $7.7M 7.6M 1.02
Transcept Pharmaceuticals 1.6 $7.5M 1.2M 6.20
Biomarin Pharmaceutical Inc bond cv 1.5 $7.2M 3.0M 2.40
MannKind Corporation 1.4 $6.7M 2.9M 2.29
Savient Pharmaceuticals 1.2 $5.9M 39k 154.50
Oncothyreon 1.0 $4.7M 1.0M 4.68
Dendreon Corp cnv 0.9 $4.3M 4.0M 1.08
Endocyte 0.8 $3.8M 466k 8.22
Neoprobe 0.7 $3.4M 921k 3.72
Neurocrine Biosciences (NBIX) 0.7 $3.2M 400k 7.90
alexza Pharmaceuticals 0.4 $1.7M 404k 4.24
Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) 0.1 $695k 278k 2.50
Dendreon Corporation 0.1 $589k 80k 7.40
Savient Pharmaceuticals 0.1 $517k 958k 0.54
Biosante Pharmaceuticals 0.1 $313k 123k 2.55
D Horizon Pharma 0.0 $43k 6.1k 7.07
Galectin Therapeutics Wrnt W Exp 3/28/2017 0.0 $21k 51k 0.42